- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05215314
Brain and Meditation (BAM) Study
Neurobiological Mechanisms of Perceived Stress and Their Modification Through Behavioral Intervention
Study Overview
Detailed Description
Participants will be randomized into one of two groups: the intervention group or the waitlist control group. The intervention group will use a mobile health app for four weeks. Participants will complete pre-intervention, weekly, post-intervention, and 3-month follow-up surveys and tasks.
Primary Objective: Test for hypothesized group differences in perceived stress during participation in a 4-week meditation program and at 3-month follow-up.
Secondary Objective: Within the meditation group, determine whether reductions in perceived stress are associated with changes in hippocampal-dependent behavior.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53703
- Center for Healthy Minds
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individual can read, write, speak, and understand English
- Able to provide informed consent
- Willing and able to complete all study procedures, including the Healthy Minds Program
- Has access to a smartphone that can download apps from Google Play or the Apple App Store
- US citizen or a permanent US resident (green card holder)
Exclusion Criteria:
- Extensive experience in meditation practice (e.g., regular daily meditation practice for the past 6 months or regular weekly meditation practice for the past 12 months), experience in substantively similar meditation training programs (e.g., attended a meditation retreat or a yoga/body practice retreat with a significant mediation component), or substantial previous use of the Healthy Minds Program app
- Individuals will be excluded if they previously participated in substantively similar research at our Center at the discretion of the investigator due to similar tasks being used in certain studies
- History of psychosis
- History of mania
- Current psychopathology that interferes with study participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy Minds Program (HMP)
Fully remote, 4-week meditation intervention
|
Participants will receive access to the 4-week Healthy Minds Program (HMP) Foundations module.
The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training.
The program is grounded in constituents of psychological well-being identified in empirical literature.
HMP provides core content, with instruction administered through a curriculum of guided practices.
HMP is based on research on eudaimonic well-being (e.g., environmental mastery, purpose) and brain-based skills that underlie these qualities (e.g., regulation of attention, mental flexibility).
The full HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose.
At post-treatment, participants will be given access to additional HMP content to support their continued practice.
Other Names:
|
|
No Intervention: Waitlist Control
Control participants will not complete the Healthy Minds Program during the study, but can use it after they have completed the study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Perceived Stress Scale (PSS) Score
Time Frame: Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
PSS is a 10-item survey scored on a 5 point likert scale from 0 = never to 4 = very often, for a total possible range of scores from 0-40 where higher scores indicate higher perceived stress.
|
Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Behavioral Pattern Separation Task
Time Frame: Baseline, following week 4 of intervention period, and 3 month follow-up
|
Participants will complete a behavioral pattern separation task .
During this task, participants will encode pictures of common objects while performing a basic categorization task.
Participants will then label pictures as "Old" (targets, identical objects to those in the encoding phase), "New" (foils, or completely novel objects), or "Similar" (lure items, distinct exemplars of objects seen during encoding).
The measure of interest on this task is the "Lure Discrimination Index", which is calculated as the proportion of lures correctly identified as "similar" minus the proportion of foils that are incorrectly identified as "similar".
The theoretical range for the pattern separation index is [-1,1], with higher scores indicating better performance.
|
Baseline, following week 4 of intervention period, and 3 month follow-up
|
|
Change in PROMIS Depression Score
Time Frame: Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
The PROMIS Depression Score is a measure of feelings of depression in the past 7 days.
This is a computer-adaptive survey scored on a 5 point likert scale from 1 (never) to 5 (always) with higher scores indicating increased depression.
For analysis, total scores will be converted to t scores with a mean of 50 and SD of 10.
Higher t scores indicate higher levels of depression.
A t score >= 59.9 is indicative of moderate depression, a t score >= 65.8 is indicative of moderately severe depression, and a t score >= 71.5 is indicative of severe depression (based on corresponding cutoffs on the Patient Health Questionnaire-9).
|
Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
|
Change in PROMIS Anxiety Score
Time Frame: Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
The PROMIS Anxiety Score is a measure of feelings of anxiety in the past 7 days.
This is a computer-adaptive survey scored on a 5 point likert scale from 1 (never) to 5 (always) with higher scores indicating increased anxiety.
For analysis, total scores will be converted to t scores with a mean of 50 and SD of 10.
Higher t scores indicate higher levels of anxiety.
A t score >= 62.3 is indicative of moderate anxiety and a t score >= 67.7 is indicative of severe anxiety (based on corresponding cutoffs on the General Anxiety Disorder-7).
|
Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Posttraumatic Stress Disorder Checklist (PCL-5) Score
Time Frame: Baseline, following week 4 of intervention period, and 3 month follow-up
|
The PCL-5 is a 20-item survey scored on a 5 point likert scale from 0 (not at all) to 4 (extremely) for a total possible range of score from 0-80 where higher scores indicate more symptoms of PTSD within the last 30 days.
|
Baseline, following week 4 of intervention period, and 3 month follow-up
|
|
Change in Five-facet Mindfulness Questionnaire: Awareness Subscale (FFMQ-A8) Score
Time Frame: Baseline, following week 4 of intervention period, and 3 month follow-up
|
The FFMQ-A8 is an 8-item survey scored on a 5 point likert scale from 'never, or very rarely true' to 'very often or always true', for a total possible range of scores from 8-40 where higher scores indicate greater mindfulness awareness.
|
Baseline, following week 4 of intervention period, and 3 month follow-up
|
|
Change in Healthy Minds Index (HMI) Score
Time Frame: Baseline and following week 4 of intervention period
|
HMI is a 17-item survey scored on a 5 point likert scale from 0 (never, none, not at all) to 4 (always, every time, to the highest degree) that assesses awareness, connection, insight, and purpose.
Higher scores indicate higher sense of awareness, connection, insight, and purpose.
Mean score for each subscale will be reported.
|
Baseline and following week 4 of intervention period
|
|
Change in PROMIS Sleep Disturbance Score
Time Frame: Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
The PROMIS Sleep Disturbance Score is a measure of sleep in the past 7 days.
This is a computer-adaptive survey scored on a 5 point likert scale with higher scores indicating increased sleep disturbance.
For analysis, total scores will be converted to t scores with a mean of 50 and SD of 10.
Higher t scores indicate higher levels of sleep disturbances.
A t score >= 45.1 is indicative of significant sleep disturbances (based on a corresponding cutoff of >= 5 on the Pittsburgh Sleep Quality Index).
|
Baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
|
|
Change in NIH Toolbox Loneliness Score
Time Frame: Baseline, following week 4 of intervention period, and 3 month follow-up
|
NIH toolbox Loneliness is a 5-item survey scored on a 5 point likert scale.
The average score is taken across items for a total possible range of scores from 1-5, where higher scores indicate increased loneliness.
|
Baseline, following week 4 of intervention period, and 3 month follow-up
|
|
Change in Roaming Entropy
Time Frame: Exploratory analyses will examine linear and nonlinear trajectories of change from baseline through 3-month follow-up
|
Roaming entropy will be calculated according to the formula in Heller et al. (2020).
Using continuous GPS location tracking, the measure takes into account distance traveled and distinct locations visited, with a single resulting value reflecting the diversity of movement through one's lived environment (Measured continuously throughout study participation)
|
Exploratory analyses will examine linear and nonlinear trajectories of change from baseline through 3-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dan Grupe, PhD, University of Wisconsin, Madison
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2021-1109
- A483000 (Other Identifier: UW Madison)
- Protocol Version 10/12/2022 (Other Identifier: UW Madison)
- 5K01MH117222 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The investigators may share coded data with researchers to address future research questions not included in this application, with a complementary study being conducted at the Center for Healthy Minds which is utilizing many of the same survey and behavioral task measures, and/or with journals where open data sharing policies are encouraged or are a requirement for publication. Coded data may be shared as Supplemental Information uploaded to journal websites.
The investigators may share fully de-identified data from the study on data sharing platforms (e.g., OSF, NIMH Data Archive) for use by non-collaborators. Data shared on data sharing platforms will be uploaded via the internet. Confidentiality will be protected by stripping the data of all identifiers, including HIPAA identifiers.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
Dana-Farber Cancer InstituteCompletedStress | Post Traumatic Stress Disorder | Work Related StressUnited States
Clinical Trials on mHealth Meditation
-
Fatima Jinnah Women UniversityNot yet recruitingType 2 Diabetes Risk Reduction in Young AdultsPakistan
-
NYU Langone HealthWeizmann Institute of Science; American Heart AssociationCompletedOverweight and Obesity | Pre-diabetesUnited States
-
Liverpool John Moores UniversityLiverpool Heart and Chest Hospital NHS Foundation Trust; University Hospitals... and other collaboratorsCompleted
-
AdventHealth UniversityRecruitingPhysical Activity | Cardiac RehabilitationUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
Samsung Medical CenterCompletedBreast CancerKorea, Republic of
-
University of California, San FranciscoCompleted
-
University of PaviaRecruiting